Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-ri

Posted Apr 26 by Two Blokes

First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu

Source: Two Blokes Trading

Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-ri

Posted Apr 26 by Two Blokes

First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu

Source: Two Blokes Trading

Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo\u2122 robotic-assisted surger

Posted Apr 26 by Two Blokes

Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted

Source: Two Blokes Trading

Here's Why Rivian Stock Is a Buy Before May 6

Posted Apr 26 by Two Blokes

Rivian (RIVN 4.42%) is expected to report earnings on May 6. So far this year, shares of the EV maker have bee

Source: Two Blokes Trading

1 No-Brainer AI Stock Down 27% to Buy the Dip on Right Now (Hint: It's Not Nvidia)

Posted Apr 26 by Two Blokes

There's no question that 2025 has been a rough year for AI stocks thus far.

Source: Two Blokes Trading

2 Growth Stocks to Buy on the Dip if the Market Crashes Again

Posted Apr 26 by Two Blokes

Anxious investors who picked April to go on a long internet-free vacation couldn't have planned it better. Ear

Source: Two Blokes Trading

2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

Posted Apr 26 by Two Blokes

Many investors are withdrawing their money from the stock market right now, but those focused on the long term

Source: Two Blokes Trading

1 Superstar Dividend Growth Stock to Buy if the Market Crashes

Posted Apr 26 by Two Blokes

The stock market has entered a new period of increased uncertainty and volatility following the Trump Administ

Source: Two Blokes Trading

ExxonMobil Continues to Capture More of This Potentially $4 Trillion Future Market Opportunity

Posted Apr 26 by Two Blokes

ExxonMobil (XOM -0.03%) believes that carbon capture and sequestration (CCS) represents a massive opportunity

Source: Two Blokes Trading

Pfizer's Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder C

Posted Apr 26 by Two Blokes

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST tria

Source: Two Blokes Trading

Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients

Posted Apr 26 by Two Blokes

Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than

Source: Two Blokes Trading

Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical ben

Posted Apr 26 by Two Blokes

Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than

Source: Two Blokes Trading